Later On

Based on a recommendation from a commenter, I got a copy of Good Calories, Bad Calories, by Gary Taubes (also available on Amazon). It’s a fascinating book, and I highly recommend it. Here’s one passage, somewhat long, that gives you a sample of the book. This starts on page 34:

"A common feature of epidemiological data is that they are almost certain to be biased, of doubtful quality, or incomplete (and sometimes all three," explained the epidemiologist John Bailar in The New England Journal of Medicine in 1980. "problems do not disappear even if one has flawless data, since the statistical associations in almost any nontrivial set of observations are subject to many interpretations. This ambiguity exists because of the difficulty of sorting out causes, effects, concomitant variables, and random fluctuations when the causes are multiple or diffuse, the exposure levels low, irregular, or hard to measure, and the relevant biologic mechanisms poorly understood. Even when the data are generally accepted as accurate, there is much room for individual judgment, and the considered conclusions of the investigators on these matters determine what they will label ’cause’ . . ."

The only way to establish cause and effect with any reliability is to do "controlled" experiments, or controlled trials, as they’re called in medicine. Such trials attempt to avoid all the chaotic complexities of comparing populations, towns, and ethnic groups. Instead, they try to create two identical situations—two groups of subjects, in this case—and then change only one variable to see what happens. They "control" for all the other possible variables that might affect the outcome being studied. Ideally, such trials will randomly assign subjects into an experimental group, which receives the treatment being tested—a drug, for instanc4e, or a special diet—and a group, which receives a placebo or eats their usual meals or some standard fare.

Not even randomization, though, is sufficient to assure that the only meaningful difference between the experimental group and the control group is the treatment being studied. This is why, in drug trials, placebos are used, to avoid any distortion that might occur when comparing individuals who are taking a pill in the belief that their condition might improve with individuals who are not. Drug trials are also done double-blind, which means neither subjects nor physicians know which pills are placebos and which are not. Double-blind, placebo-controlled clinical trials are commonly referred to in medicine as the gold standard for research. It’s not that they are better than other methods of establishing truth, but that truth, in most instances, cannot be reliably established without them.

Diet trials are particularly troublesome, because it’s impossible to conduct them with placebos or a double-blind. Diets including copious meat, butter, and cream do not look or taste like diets without them. It is also impossible to make a single change in a diet. Saturated fats cannot be eliminated from the diet without decreasing calories as well. To ensure that calories remain constant, another food has to replace the saturated fats. Should polyunsaturated fats be added, or carbohydrates? A single carbohydrate or mixed carbohydrates? Green leafy vegetables or starches? Whatever the choice, the experimental diet is changed in at least two significant ways. If saturated-fat calories are reduced and carbohydrate calories are increased to compensate, the investigators have no way to know which of the two was responsible for any effect observed. (To state that "saturated fats raise cholesterol," as is the common usage, is meaningful only if we say that saturated fat raises cholesterol compared with the effect of some other nutrient in the diet—polyunsaturated fats, for instance.)

Nonetheless, dietary trials of diet and heart disease began appearing in the literature in the mid-1950s. Perhaps a dozen such trials appeared over the next twenty years. The methods used were often primitive. Many had no controls; many neglected to randomize subjects into experimental and control groups.

Only two of these trials actually studied the effect of a low-fat diet on heart-disease rates—not to be confused with a cholesterol-lowering diet, which replaces saturated with polyunsaturated fats and keeps the total fat content of the diet the same. Only these two trials ever tested the benefits and risks of the kind of low-fat diet that the American Heart Association has recommended we eat since 1961, and the USDA food pyramid recommends when it says to "use fats and oils sparingly." One, published in a Hungarian medical journal in 1963, concluded that cutting fat consumption to only 1.5 ounces a day reduced heart-disease rates. The other, a British study, concluded that it did not. In the British trial, the investigators also restricted daily fat consumption to 1.5 ounces, a third of the fat in the typical British diet. Each day, the men assigned to this experimental diet, all of whom had previously had heart attacks, could eat only half an ounce of butter, three ounces of meat, one egg, and two ounces of cottage cheese, and drink two ounces of skim milk. After three years, average cholesterol levels dropped from 260 to 235, but the recurrence of heart disease in the control and experimental groups was effectively identical. "A low-fat diet has no place in the treatment of myocardial infarction," the authors concluded in 1965 in The Lancet.

In all other trials, cholesterol levels were lowered by changing the fat content of the diet, rather than the total amount of fat consumed. Polyunsaturated fats replaced saturated fats, without altering the calorie content. These diet trials had a profound influence on how the diet/heart-disease controversy played out.

The first and most highly publicized was the Anti-Coronary Club Trial, launched in the late 1950s by New York City Health Department Director Norman Jolliffe. The eleven hundred middle-aged members of Jolliffe’s Anti-Coronary Club were prescribed what he called the "prudent diet," which included at least one ounce of polyunsaturated vegetable oil every day. The participants could eat poultry or fish anytime, but were limited to four meals a week containing beef, lamb, or pork. This made Jolliffe’s prudent diet a model for future health-conscious Americans. Corn-oil margarines, with a high ratio of polyunsaturated to saturated fat, replaced butter and hydrogenated margarines, which were high in saturated fats. In total, the prudent diet was barely 30 percent fat calories, and the proportion of polyunsaturated to saturated fat was four times greater than that of typical American diets. Overweight Anti-Coronary Club members were prescribed a sixteen-hundred-calorie diet that consisted of less than 20 percent fat. Jolliffe then recruited a control group to use as a comparison.

Jolliffe died in 1961, before the results were in. His colleagues, led by George Christakis, began reporting interim results a year later. "Diet Linked to Cut in Heart Attacks," reported the New York Times in May 1962. "Special Diet Cuts Heart Cases Here," the Times reported two years later. Christakis was so confident of the prudent-diet benefits, reported Newsweek, that he "urged the government to heed the club results and launch an education and food-labeling campaign to change U.S. diet habits."

The actual data, however, were considerably less encouraging. Christakis and his colleagues reported in February 1966 that the diet protected against heart disease. Anti-Coronary Club members who remained on the prudent diet had only one-third the heart disease of the controls. The longer you stayed on the diet, the more you benefited, it was said. But in November 1966, just nine months later, the Anti-Coronary Club investigators published a second article, revealing that twenty-six members of the club had died during the trial, compared with only six of the men whose diet had not been prudent. Eight members of the club died from heart attacks, but none of the controls. This appeared "somewhat unusual," Christakis and his colleagues acknowledged. They discussed in the improvements in heart-disease risk factors (cholesterol, weight, and blood pressure decreased) and the significant reduction in debilitating illness "from new coronary heart disease," but omitted further discussion of mortality.

This mortality problem was the bane of Keys’s dietary-fat hypothesis, bedeviling every trial that tried to assess the effects of a low-fat diet on death as well as disease. In July 1969, Seymour Dayton, a professor of medicine at the University of California, Los Angeles, reported the results of the largest diet-heart trial to that date. Dayton gave half of nearly 850 veterans residing at a local Veterans Administration hospital a diet in which corn, soybean, safflower, and cottonseed oils replaced the saturated fats in butter, milk, ice cream, and cheeses. The other half, the controls, were served a placebo diet in which the fat quantity and type hadn’t been changed. The first group saw their cholesterol drop 13 percent lower than the controls; only sixty-six died from heart disease during the study, compared with ninety-six of the vets on the placebo diet.*

Thirty-one of the men eating Dayton’s experimental cholesterol-lowering diet, however, died of cancer, compared with only seventeen of the controls. The risk of death was effectively equal on the two diets. "Was it not possible," Dayton asked, "that a diet high in unsaturated fat . . . might have noxious effects when consumed over a period of many years? Such diets are, after all, rarities among the self-selected diets of human population groups." Because the cholesterol-lowering diet failed to increase longevity, he added, it could not provide a "final answer concerning dietary prevention of heart disease."

* When Dayton and his colleagues autopsied the men who died, they found no difference in the amount of atherosclerosis between those on the two diets.

He also has a fascinating report on the dubious origins of the Mediterranean diet:

Now the story changed: High cholesterol did not predict increased mortality, despite its association with a greater rate of heart disease. Saturated fat in the diet ceased to be a factor as well. The U.S. railroad workers, for instance, had a death rate from all causes lower—and so a life expectancy longer—than the Finns, the Italians, the Yugoslavs, the Dutch, and particularly the Japanese, who ate copious carbohydrates, fruits, vegetables, and fish. Only the villagers of Crete and Corfu could still expect to live significantly longer than the U.S. railroad workers. Though this could be explained by other factors, it still implied that telling Americans to eat like the Japanese might not be the best advice. This was why Keys had begun advocating Mediterranean diets, though evidence that the Mediterranean diet was beneficial was derived only from the villagers of Crete and Corfu in Keys’s study, and not from those who lived on the Mediterranean coast of Yugoslavia or in the cities of Italy.